Medication-Related Impacts on Pediatric Bone Health
Authors:
- Charu JainCJCharu Jain
- Luca ValdiviaLVLuca Valdivia
- Laurel WongLWLaurel Wong
- Sheena C. RanadeSRSheena C. Ranade
Open Access
- 5 September 2025
- journal article
- Published by Elsevier in Journal of the Pediatric Orthopaedic Society of North America
- Vol. 13
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 PandemicJAMA Network Open, 2024
- 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisArthritis & Rheumatology, 2022
- Association Between Proton Pump Inhibitor Use and Risk of Fracture in ChildrenJAMA Pediatrics, 2020
- Glucocorticoids for Croup in ChildrenJAMA Pediatrics, 2019
- The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysisDepression and Anxiety, 2017
- Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity DisorderJAMA Pediatrics, 2016
- Treatment of Young People With Antipsychotic Medications in the United StatesJAMA Psychiatry, 2015
- Efficacy and Safety of Histamine-2 Receptor AntagonistsJAMA Pediatrics, 2014
- National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based PhysiciansJAMA Psychiatry, 2014
- A Prospective Study of Falls After Benzodiazepine Use: A Comparison of New and Repeat UsePharmacoepidemiology and Drug Safety, 1997